LTR Pharma Ltd (LTP) — Net Asset Quality Index
LTR Pharma Ltd (LTP) has a Net Asset Quality Index of 98.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$27.32 Million minus total liabilities of AU$457.81K yields net assets of AU$26.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of LTR Pharma Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
LTR Pharma Ltd Net Asset Quality Index Over Time (2021–2025)
This chart shows how LTR Pharma Ltd's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 98.3%, representing net assets of AU$26.86 Million against total assets of AU$27.32 Million AUD. Explore LTR Pharma Ltd cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for LTR Pharma Ltd (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for LTR Pharma Ltd from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see LTP market cap overview.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.8% | AU$31.51 Million | AU$32.21 Million | AU$700.57K | ▲ +10.5 pp |
| 2024 | 87.3% | AU$2.94 Million | AU$3.37 Million | AU$428.54K | ▼ -11.7 pp |
| 2023 | 99.0% | AU$2.07 Million | AU$2.09 Million | AU$21.26K | ▲ +20.2 pp |
| 2022 | 78.8% | AU$1.77 Million | AU$2.25 Million | AU$475.91K | ▲ +88.5 pp |
| 2021 | -9.7% | AU$-40.80K | AU$422.70K | AU$463.50K | — |